IGH gene clone type detection multiplex PCR primer group, design method and application
Through weighted scoring and penalty screening methods designed based on the conserved region of the IGH gene, multiple PCR primers group of IGH genes were constructed, which solved the problems of incomplete coverage, low efficiency and insufficient sensitivity of IGH gene clonotype detection in the prior art, and achieved high efficiency , accurate clonotype amplification and monitoring, suitable for detection of early hematologic tumor recurrence.
Patent Information
- Application Number
- CN202411282310.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-12
- Publication Date
- 2024-11-12
- Estimated Expiration
- 2044-09-12
AI Technical Summary
The prior art has problems such as incomplete coverage, low efficiency, difficulty in rapid update and adaptation of different amplification reagents, low utilization of amplification product sequencing data and insufficient detection sensitivity when designing multiple PCR primers of IGH genes, especially in monitoring hematological tumors. The micro-residual markers in relapse are being detected.
The primer pool is designed based on the conserved regions of the IGH gene, and high-quality primer groups are obtained through weighted scoring and penalty screening to ensure that the primer groups can cover all clonal patterns, and the concentration is adjusted by constructing the plasmid sequence of different primers to achieve accurate quantification and high sensitivity. detection.
It realizes efficient amplification and accurate quantification of IGH gene clonotypes, improves the coverage and sensitivity of detection, can quickly adapt to new clonotypes and reagent changes, and ensures early monitoring of blood tumor recurrence.
Smart Images

Figure CN118932067A_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the technical field of gene detection, and in particular relates to a multiplex PCR primer set for detecting IGH gene clonotypes, a design method and an application thereof. Background Art
[0002] For patients with blood tumors, although the remission rate of blood tumors is very high now, the overall treatment remission rate of children with acute lymphoblastic leukemia has reached 95%, and the overall treatment remission rate of adult acute lymphoblastic leukemia has reached 70%, but tumor recurrence is still one of the main problems faced by clinicians and patients. Therefore, it is crucial to detect the residual tumor cells in the body after remission, namely minimal residual disease (MRD), earlier and more sensitively, and to detect signs of tumor recurrence earlier.
[0003] The immune repertoire can be used to monitor patients for signs of relapse. The immune repertoire refers to the sum of all functionally diverse T / B lymphocytes of an individual at a specific time point. T / B cells use cell surface receptors (TCR / BCR) to recognize and bind to antigens, mediating the body's targeted immune response. There is an area in TCR / BCR called the complementary determining region (CDR). Different CDR sequences can recognize different antigens, and it plays a key role in antigen recognition. CDR consists of CDR1, CDR2, and CDR3, of which CDR3 has the highest degree of diversity. CDR1 and CDR2 are encoded by V genes, and CDR3 is encoded by three genes in the variable region V, D, and J. The characteristics of the immune repertoire of patients with hematological tumors at the time of relapse are consistent with those at the time of initial diagnosis, that is, the content of a certain clonal sequence of the immune repertoire gene has increased significantly. Based on this feature, the characteristics of the immune repertoire can be used to monitor whether patients have signs of relapse after remission, intervene in treatment earlier, and improve the quality of life and survival rate of patients.
[0004] There are also products on the market that use DNA capture and high-depth sequencing to monitor minimal residual disease. However, if the patient's variant site does not fall within the design range of the DNA capture probe, the capture probe needs to be redesigned, which is more expensive and time-consuming than immune repertoire technology, and has a higher probability of producing false negatives.
[0005] There are also two methods for monitoring minimal residual disease in the immune repertoire. One is the capillary electrophoresis fragment analysis of the traditional first-generation sequencing platform; the other is to amplify the immune repertoire sequence through multiplex PCR, followed by high-throughput sequencing analysis. In comparison, the first-generation sequencing method has low detection sensitivity and cannot distinguish immune repertoire clones of similar length. The multiplex PCR and second-generation sequencing methods take into account both sensitivity and the detection range of the immune repertoire.
[0006] The immune repertoire contains genes such as IGH, IGK, IGL, TRB, TRD, and TRG. Among them, the IGH gene has the most clonal types. The clonal type characteristics of this gene are often used clinically to monitor tumor recurrence. However, the following problems exist when designing multiplex PCR primers for the IGH gene of the immune repertoire:
[0007] (1) There are many IGH clonal types, making it difficult to obtain a primer pool with comprehensive coverage and high working efficiency;
[0008] (2) The IMGT database is updated frequently, making it difficult to quickly update the primer pool adapted to new clonal types while maintaining compatibility with the original primer pool;
[0009] (3) The primer pool is difficult to adapt to different multiplex PCR amplification reagent systems. The amplification primers have different affinities for different multiplex PCR amplification reagents, making it difficult to quickly adjust the primer pool to adapt to various multiplex PCR amplification reagents;
[0010] (4) It is difficult to obtain the true content of clonal types. Monitoring requires obtaining the true content ratio of different IGH clonal types, but the amplification efficiency of primers is different. The content of amplified clonal types is highly correlated with the primer amplification efficiency. Therefore, it is difficult to obtain the true proportion of each IGH clonal type. If UMI tags are introduced, although the problem of quantitative accuracy can be solved, it will lead to a significant decrease in detection sensitivity, that is, the detection performance will be greatly reduced;
[0011] (5) The utilization rate of sequencing data of amplified products is low, and some sequencing data cannot detect clonal types. When sequencing the amplicon sequence using the second-generation sequencing platform, the base sequence information of 150bp on both sides of the amplicon can be measured, and the key CDR3 region is located in the middle of the amplicon. If the amplicon is too long, the CDR3 region is easily missed, resulting in the inability to detect the corresponding clonal type. If the amplicon is too short, the CDR3 region may be incomplete, resulting in the inability to confirm which clonal type it is. Summary of the invention
[0012] The purpose of the present invention is to propose that it is necessary to provide a multiplex PCR primer set and a design method for detecting IGH gene clonotypes, so as to at least solve one of the above-mentioned defects of the prior art.
[0013] In view of this, the scheme of the present invention is as follows:
[0014] In a first aspect of the present invention, a PCR primer set for detecting IGH gene clonotypes is provided, comprising primers having nucleotide sequences as shown in SEQ ID NOs: 1-57.
[0015] The second aspect of the present invention provides an IGH gene clonotype detection kit comprising the PCR primer set described in the first aspect.
[0016] The third aspect of the present invention provides the use of the PCR primer set described in the first aspect in preparing an IGH gene clonotype detection product.
[0017] A fourth aspect of the present invention provides a method for designing a multiplex PCR primer set for detecting IGH gene clonotypes, comprising:
[0018] A primer pool was designed based on the conserved region of the IGH gene;
[0019] Based on the scoring criteria, each primer is weighted and scored; the scoring criteria include primer quality parameters, highly conserved base content, and the number of covered clones;
[0020] Take at least one primer with a score higher than the threshold as the candidate primer for each clonal type;
[0021] Penalty screening is performed on each clonal primer, and the primers with penalty scores greater than 0 are replaced with primers with the next highest scores and the screening process is repeated until the primer penalty scores of each clonal primer are 0 to obtain a multiplex PCR primer set; the penalty objects include: formation of primer dimers, too long sequence length, and incomplete CDR3.
[0022] Furthermore, the primer quality parameters include primer length, primer GC content, primer terminal first base type, primer terminal third base type, primer base complexity, possibility of forming a hairpin structure, and whether there are 5 consecutive GC bases.
[0023] Preferably, the weighted scoring formula is: s=a+b+c+d+e-f+g+5h+2i; wherein:
[0024] a is the primer length score,
[0025] b value is the GC base content ratio of the primer sequence;
[0026] c is the score of the base at the end of the primer. If the base is A, then c = 0, otherwise c = 1;
[0027] d is the score of the three base types at the end of the primer. If the three bases are abbreviated as SSA, the value of d is 1.25. If the three bases are abbreviated as SWC or SWG, the value of d is 1.5. In other cases, the value of d is 1.
[0028] e is the primer base complexity score, which is calculated and scored based on kmer, 0≤e≤1;
[0029] F is the probability score of forming a hairpin structure;
[0030] g is a score indicating whether there are 5 consecutive GC bases. If so, the value is 0, otherwise, it is 1.
[0031] h is the highly conserved base content score, which is the ratio of the number of bases in the conserved region to the primer length;
[0032] i is the score of the number of covered clonotypes, which is the ratio of the number of covered clonotypes to the total number of clonotypes.
[0033] Furthermore, the method for judging whether the sequence length is too long is that the sum of the length of the amplified sequence corresponding to the V / D region primer and the length of the amplified sequence corresponding to the J region primer is greater than a length threshold.
[0034] Furthermore, the IGH gene clonotype detection multiplex PCR primer set includes primers with nucleotide sequences as shown in SEQ ID NOs: 1-57.
[0035] A fifth aspect of the present invention provides a method for constructing a multiplex PCR amplification system for detecting IGH gene clonotypes, comprising the steps of primer design and concentration adjustment; the primer design uses the primer set described in the first aspect, or is designed according to the design method described in the fourth aspect.
[0036] Furthermore, the concentration adjustment process includes constructing plasmid sequences of different primers, adjusting the primer concentration by analyzing the actual content of amplicons and amplification product content corresponding to different primers, thereby achieving accurate quantification while also ensuring the sensitivity of detection.
[0037] Compared with the prior art, the beneficial effects of the present invention include but are not limited to:
[0038] The multiplex PCR primer set of the present invention can specifically amplify each clonotype sequence of the IGH gene, and basically all clonotypes can be well detected, with good working efficiency and high coverage of IGH clonotypes, thus meeting the clinical demand for monitoring tumor recurrence based on clonotype characteristics.
[0039] The primer set design method of the present invention sets up an IGH candidate primer database by setting a weighted scoring mechanism, sets a penalty mechanism to screen primers, and can quickly replace primers when a new clonal type appears or an amplification reagent changes; strictly controls the length range of amplification products corresponding to the F-terminal primer and the length range of amplification products corresponding to the R-terminal primer, so as to ensure that various clonal type sequences are well amplified, sequenced and detected; constructs plasmid sequences of different primers, analyzes the actual content of amplicons corresponding to different primers and the content of amplification products, and adjusts the primer concentration, so as to achieve accurate quantification while also ensuring the sensitivity of detection. BRIEF DESCRIPTION OF THE DRAWINGS
[0040] In order to more clearly illustrate the technical solutions in the embodiments of the present invention, the following briefly introduces the drawings required for use in the description of the embodiments. Obviously, the drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without creative work.
[0041] Figure 1 The present invention provides a flowchart for designing the PCR primer pool for detecting IGH gene clonotypes.
[0042] Figure 2 It is a schematic diagram of the multiple sequence alignment results of the IGH gene described in the present invention.
[0043] Figure 3 Schematic diagram of primer amplification deviation before and after adjustment of the multiplex PCR amplification system of the present invention. DETAILED DESCRIPTION
[0044] The following provides definitions of some terms used in this specification. Unless otherwise specified, all terms used herein are generally understood by those skilled in the art to which this solution belongs.
[0045] Terminology explanation:
[0046] Primer dimer: refers to the double-stranded DNA structure formed by two primers pairing with each other in the polymerase chain reaction (PCR), rather than the structure formed by the primers pairing with the target DNA template.
[0047] In one embodiment, the inventors found that based on a variety of scoring indicators, a high-quality primer pool for each IGH clonotype can be obtained to ensure that the IGH gene primer pool can better cover all clonotypes and has good amplification efficiency; an IGH candidate primer database is built, and when a new clonotype appears or the amplification reagent changes, the primers can be quickly replaced; the length range of the amplification product corresponding to the F-terminal primer and the length range of the amplification product corresponding to the R-terminal primer are strictly controlled to ensure that various clonotype sequences are well amplified, sequenced and detected; plasmid sequences of different primers are constructed, and the actual content of the amplicon and the content of the amplification product corresponding to different primers are analyzed to adjust the primer concentration, thereby achieving accurate quantification while also ensuring the sensitivity of detection.
[0048] In the above embodiment, the primer design process is as follows Figure 1 As shown, the specific steps are as follows:
[0049] 1. Identification of IGH conserved regions
[0050] Download the reference sequences of each clonotype of IGH from the IMGT database, perform multiple sequence alignment on these sequences, and obtain the conservation score of each base. Prioritize the conservative region as the target, use as few primers as possible to cover all clonotypes, so as to minimize the impact of primer amplification efficiency on clonotype quantification; prioritize the conservative region for primer design to avoid mutations in the primer region, which may cause the clonotype to be unable to be amplified. An example of the multiple sequence alignment result is shown below: Figure 2 shown.
[0051] 2. Construction of candidate primer pool
[0052] Primer3 was used to design primer sequences based on the conserved regions to obtain a candidate primer pool.
[0053] 3. Primer database construction
[0054] Based on the primer length, primer GC content, primer terminal base type, primer terminal base type, primer base complexity, hairpin structure possibility score, whether there are 5 consecutive GC bases, highly conserved base content, and the number of covered clonal types, each primer is scored, and the primers of each clonal type are sorted from high to low according to the score to form an immune repertoire IGH gene primer candidate database. The database contains the above-mentioned scores, overall scores, and primer corresponding to the amplification sequence length information.
[0055] The primer length score is denoted as a, The GC content score of the primer is recorded as b, and its value is equal to the GC base content ratio of the primer sequence. The score of the base at the end of the primer is recorded as c. If the base is A, then, and vice versa. The score of the three base types at the end of the primer is recorded as d. If the three bases are abbreviated as "SSA", the value of d is 1.25. If the three bases are abbreviated as "SWC" or "SWG", the value of d is 1.5. Other cases are recorded as 1 (W and S are degenerate bases, "W" represents the base "A" or "T", and "S" represents the base "C" or "G"). The primer base complexity score is recorded as e, and its score is calculated based on kmer, with a maximum of 1 and a minimum of 0. The score for the possibility of forming a hairpin structure is recorded as f, which is calculated by primer3. The higher the value, the more likely it is to form a hairpin structure. Whether there are 5 consecutive GC bases is scored as g. If so, the value is 0, otherwise it is 1. The score for highly conserved base content is recorded as h, The score of the number of covered clonotypes is denoted as i,
[0056] The total primer score is scored as follows:
[0057] s=a+b+c+d+e-f+g+5h+2i.
[0058] 4. Select the initial IGH primer pool
[0059] The primer with the highest score for each clonotype in the database was taken as the initial primer pool.
[0060] 5. Initial Primer Pool Optimization
[0061] ① Primer dimer evaluation. Use the software mfeprimer to evaluate the primer dimers in the initial primer pool. Each time a primer participates in the formation of a primer dimer, its penalty score increases by one.
[0062] ②Simulate the length of all clonal types, add the length of the amplified sequence corresponding to the V / D region primer and the length of the amplified sequence corresponding to the J region primer. If the added length is greater than 280bp, it is recorded as the length of the amplified product may be too long, and the penalty point is increased by one;
[0063] ③Simulate all clonal type sequences and use igblast to evaluate them to ensure that the sequences amplified by the primers contain the complete CDR3 region. If the CDR3 is incomplete, the corresponding primer penalty is increased by one.
[0064] For each clonotype, primers with penalty scores greater than 0 were replaced with primers with suboptimal scores for that clonotype in the primer database.
[0065] 6. Primer pool iterative optimization
[0066] Repeat the optimization work in step 5 until all primer penalties in the primer pool are 0, that is, the final primer pool of the immune repertoire IGH gene is obtained. At this point, there are no primer dimers in the primer pool, the primer amplification efficiency is good, the amplification product length of all clonal types is in line with expectations, and all contain complete CDR3 sequences.
[0067] 7. Adjustment of multiplex PCR amplification system
[0068] Construct fragments amplified by different primers and insert them into plasmid vectors. Then transform the plasmids into E. coli. Confirm the positive clones by antibiotic screening and sequencing to ensure that the inserted fragment sequence is correct. Extract plasmid DNA from positive clones and quantify the concentration of plasmid DNA using a spectrophotometer. Dilute the plasmids in a certain proportion to establish a standard curve. Use the final primer pool of the immune repertoire IGH gene to perform PCR amplification on plasmids of different dilutions. Then use qPCR to analyze the concentration of the PCR product. According to the concentration of the PCR product, adjust the working concentration of each primer so that the content of the clonal sequence amplification product is consistent with the actual concentration ratio.
[0069] The ratio of the amplified product concentration to the actual concentration was compared and recorded as the deviation. As shown in the figure below, after the primer concentration was adjusted, the deviation between the amplified product and the actual concentration approached 1, indicating that after the primer concentration was adjusted, the multiplex PCR amplification system could be used to accurately quantify each IGH clonal type.
[0070] At this point, a multiplex PCR primer pool of the immune repertoire IGH gene has been obtained, which can well amplify each clonal sequence of IGH, and can be accurately quantified while ensuring sensitivity. If a new clonal type appears, update the original primer database, repeat steps 4-7, and quickly build a new primer pool. If the amplification reagent needs to be replaced, repeat step 7 and adjust the concentration of each primer so that the new multiplex PCR amplification system can be accurately quantified.
[0071] In a preferred embodiment, the above-mentioned design method is used to obtain a series of multiplex PCR primer pools for IGH gene clonotype detection, as shown in Table 1.
[0072] Table 1: IGH multiplex PCR primer pool
[0073]
[0074]
[0075] Peripheral blood samples were selected for nucleic acid extraction, multiplex PCR primer amplification, and NGS sequencing to verify the working effect of the primer pool. The multiplex PCR primer amplification step adopted a two-round amplification scheme. In the first round of amplification, the VAHTS Pathogen DNA & RNA Multiplex PCR Mix reagent was placed on ice to dissolve, vortexed and mixed, and the first round of PCR amplification system was configured according to Table 2, and the amplification reaction was performed according to Table 3. The second round of PCR used the Novozymes VAHTS HiFi Amplification Mix, and the PCR products were purified using VAHTS DNA Clean Beads.
[0076] Table 2: PCR amplification reaction system
[0077] Reagent components Volume (μL) 5×VAHTS RT Multi-PCR Mix 5 Primerpool-1-F / R 4 DNA template 10 <![CDATA[Nuclease-free H2O]]> 6 Total 25
[0078] Table 3: PCR amplification reaction program
[0079]
[0080] The steps for PCR product purification are as follows: VAHTS Pathogen DNA & RNA Multiplex PCR Mix amplification system: Nuclease-free ddH2O to make up the PCR system to 50μl, vortex VAHTSDNA Clean Beads to mix thoroughly, add 50μl VAHTSDNA Clean Beads (1×) and pipette or vortex to mix, and let stand at room temperature for 5min. Centrifuge briefly, place the PCR tube on the magnetic rack for 3min, and wait for the solution to clarify. Remove the supernatant completely, remove the PCR tube from the magnetic rack, add 50μL Buffer YF to the tube, pipette to mix, and let stand at room temperature for 5min. Keep the PCR tube on the magnetic rack, carefully discard the supernatant, add 180μL 80% ethanol solution to the PCR tube, and let stand for 30s. Keep the PCR tube on the magnetic rack, discard the supernatant, add 180μL 80% ethanol solution to the PCR tube again, let stand for 30s, and discard the supernatant. Put on the tube cap, centrifuge briefly, centrifuge the residual ethanol to the bottom of the tube, place the PCR tube on the magnetic rack, carefully use a 10μL pipette to remove the residual ethanol at the bottom, and be careful not to suck up the magnetic beads. Add 30μL NFW, remove the PCR tube from the magnetic rack, pipette or vortex to mix, and let it stand at room temperature for 2 minutes. Use a pipette to draw 28μL of supernatant and transfer it to a new PCR tube. The supernatant in the tube is the prepared first round of PCR purification product. Take 1μL and use Qubit4.0Fluorometer (Qubit dsDNA HS Assay Kit) for concentration determination and record the product concentration.
[0081] The working conditions of each primer are shown in Table 4. It is not difficult to see that all primers work normally.
[0082] Table 4: Primer working status
[0083]
[0084]
[0085] The detection of each clonotype of the IGH gene is shown in Table 5. More than 90% of the reads can detect the CDR3 region of the IGH gene, which can be used for clonotype determination. Basically all clonotypes are well detected, which also shows that this primer pool has good working efficiency and high coverage of IGH gene clonotypes.
[0086] Table 5: Statistics of the number of reads detected for IGH gene clonotypes
[0087]
[0088]
[0089]
[0090] Although the present invention is disclosed as above, the protection scope of the present invention is not limited thereto. Those skilled in the art may make various changes and modifications without departing from the spirit and scope of the present invention, and these changes and modifications will fall within the protection scope of the present invention.
Claims
1. A PCR primer set for detecting IGH gene clonotypes, characterized in that: The primers include nucleotide sequences shown in SEQ ID NOs: 1-57.
2. An IGH gene clonotype detection kit comprising the PCR primer set according to claim 1.
3. Use of the PCR primer set according to claim 1 in preparing an IGH gene clonotype detection product.
4. A method for designing a multiplex PCR primer set for IGH gene clonotype detection, characterized in that: include: A primer pool was designed based on the conserved region of the IGH gene; Based on the scoring criteria, each primer is weighted and scored; the scoring criteria include primer quality parameters, highly conserved base content, and the number of covered clones; Take at least one primer with a score higher than the threshold as the candidate primer for each clonal type; Penalty screening is performed on each clonal primer, and the primers with penalty scores greater than 0 are replaced with primers with the next highest scores and the screening process is repeated until the penalty scores of the primers of each clonal primer are all 0 to obtain a multiplex PCR primer set; The penalty objects include: primer dimer formation, too long sequence length, and incomplete CDR3.
5. The design method according to claim 4, characterized in that: The primer quality parameters include primer length, primer GC content, primer terminal base type, primer terminal base type, primer base complexity, possibility of forming a hairpin structure, and whether there are 5 consecutive GC bases.
6. The design method according to claim 5, characterized in that: The weighted scoring formula is: s = a + b + c + d + e-f + g + 5h + 2i; where: a is the primer length score, b value is the GC base content ratio of the primer sequence; c is the score of the base at the end of the primer. If the base is A, c = 0, otherwise c = 1; d is the score of the three base types at the end of the primer. If the three bases are abbreviated as SSA, the value of d is 1.
25. If the three bases are abbreviated as SWC or SWG, the value of d is 1.
5. In other cases, the value of d is 1. e is the primer base complexity score, which is calculated and scored based on kmer, 0≤e≤1; F is the probability score of forming a hairpin structure; g is a score indicating whether there are 5 consecutive GC bases. If so, the value is 0, otherwise, it is 1. h is the highly conserved base content score, which is the ratio of the number of bases in the conserved region to the primer length; i is the score of the number of covered clonotypes, which is the ratio of the number of covered clonotypes to the total number of clonotypes.
7. The design method according to claim 4, characterized in that: The method for judging whether the sequence length is too long is that the sum of the length of the amplified sequence corresponding to the V / D region primer and the length of the amplified sequence corresponding to the J region primer is greater than a length threshold.
8. The design method according to claim 4, characterized in that: The IGH gene clonotype detection multiplex PCR primer set includes primers with nucleotide sequences as shown in SEQ ID NOs: 1-57.
9. A method for constructing a multiplex PCR amplification system for IGH gene clonotype detection, characterized in that: The method comprises the steps of primer design and primer concentration adjustment; the primer design uses the primer set described in claim 1, or is designed according to the design method described in any one of claims 4-8.
10. The construction method according to claim 9, characterized in that: The primer concentration adjustment process includes: constructing plasmid sequences of different primers, and adjusting the primer concentration by analyzing the actual content of the amplicon corresponding to the different primers and the content of the amplified product.
Citation Information
Patent Citations
Primer and kit for detecting systemic lupus erythematosus cell B receptor repertoire
CN106319066A
Preparation method and application of library, linker and kit
CN117822130A
Nucleic acid amplification primers for PCR-based clonality studies
CN1965089A
System and Methods for Massively Parallel Analysis of Nucleic Acids in Single Cells
US20140057799A1
System and Methods for Genetic Analysis of Mixed Cell Populations
US20150154352A1
Cited By
Hematologic tumor diagnosis and treatment primer group, kit and application
CN120330335A
Primer design method and device, disease subtyping diagnosis method and device, composition, kit, and use thereof
WO2026044613A1
